CNS Pharmaceuticals Inc expected to post a loss of 8  cents a share - Earnings Preview

CNS Pharmaceuticals

09/08/2022 19:31

* CNS Pharmaceuticals Inc  CNSP.OQ   CNSP.O  is expected
to report  results 
    * ​Refinitiv's mean analyst estimate for CNS Pharmaceuticals
Inc
is for a loss of 8 cents per share. For the same quarter last
year, the company reported a loss of 15 cents per share.
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CNS
Pharmaceuticals Inc is $5.5​, above​ its last closing price
of $0.26. ​​​

This summary was machine generated August 9 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated